Download App

Log in to access Online Inquiry
Company Overview More
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children’s Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
CEO: Evans M.B.A., John M.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > BEAM Beam Therapeutics > Detailed Quotes

BEAM Beam Therapeutics

32.410-1.530-4.51%
Trading Session 05/20 13:44 ET
High
35.860
Open
34.580
Turnover
20.61M
Low
31.580
Pre Close
33.940
Volume
619.92K
Market Cap
2.28B
P/E(TTM)
Loss
52wk High
138.522
Shares
70.27M
P/E(Static)
Loss
52wk Low
27.770
Float Cap
1.93B
Bid/Ask %
0.00%
Historical High
138.522
Shs Float
59.56M
Volume Ratio
0.64
Historical Low
13.000
Dividend TTM
--
Div Yield TTM
--
P/B
2.75
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.04%
Amplitude
12.61%
Avg Price
33.251
Lot Size
1
Float Cap
1.93B
Bid/Ask %
0.00%
Historical High
138.522
Shs Float
59.56M
Volume Ratio
0.64
Historical Low
13.000
Dividend TTM
--
P/B
2.75
Dividend LFY
--
Turnover Ratio
1.04%
Amplitude
12.61%
Avg Price
33.251
Lot Size
1
Price Forecast

No Data

News

Comment